This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Reckitt Benckiser (RB.L) Reported higher quarterly sales on Friday, helped by growth across all regions, and stood by its full-year target. Sales rose 5% on a like-for-like basis, which excludes the impact of currency, acquisitions, disposals and discontinued operations. On track to meet its full-year goals for 4% like-for-like sales growth and "moderate to nice" operating margin expansion. Closing price 6001.00p (Reuters)
AstraZeneca (AZN.L) Reported FY 2015 guidance unchanged. Q1 revenue $6.06bn. Sales fell by a slightly less-than-expected 6% in Q1, hit by the launch of generic copies of its popular stomach acid pill Nexium in the vital U.S. market and the stronger dollar. Closing price 4830.00p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Pace | PIC.L | 36.19% | 44.05% | 31.21% |
| Taylor Wimpey | TW.L | 0.85% | 1.58% | -1.03% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research